Business Opportunity:
PLANTIGEN Inc. is seeking seed capital in the form of equity investment to support future research, clinical studies and business activities in preparation for a later round of public and/or private financing. Revenue during the first three years of operation is to be generated from research grants and milestone payments arising from research collaborations. The cash infusion will leverage PLANTIGEN's ability to pursue more sources of co-sponsored funding from public sector research and innovation initiatives, while seeking alliances with corporate partners. The financing will support activities to bring PLANTIGEN's pre-eminent products closer to commercialization and attract investment from larger capitalized Pharmaceutical and Biotechnology Companies.
